Connection

Dev Arya to Microbial Sensitivity Tests

This is a "connection" page, showing publications Dev Arya has written about Microbial Sensitivity Tests.
Connection Strength

0.590
  1. Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles. J Med Chem. 2017 06 22; 60(12):4904-4922.
    View in: PubMed
    Score: 0.136
  2. Antimicrobial Activity, AME Resistance, and A-Site Binding Studies of Anthraquinone-Neomycin Conjugates. ACS Infect Dis. 2017 03 10; 3(3):206-215.
    View in: PubMed
    Score: 0.134
  3. Rapid synthesis, RNA binding, and antibacterial screening of a peptidic-aminosugar (PA) library. ACS Chem Biol. 2015 May 15; 10(5):1278-89.
    View in: PubMed
    Score: 0.116
  4. Characterization of ribosomal binding and antibacterial activities using two orthogonal high-throughput screens. Antimicrob Agents Chemother. 2013 Oct; 57(10):4717-26.
    View in: PubMed
    Score: 0.104
  5. New Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents. ACS Infect Dis. 2018 02 09; 4(2):196-207.
    View in: PubMed
    Score: 0.035
  6. Eukaryotic Ribosomal Expansion Segments as Antimicrobial Targets. Biochemistry. 2017 10 10; 56(40):5288-5299.
    View in: PubMed
    Score: 0.035
  7. Influence of linker length and composition on enzymatic activity and ribosomal binding of neomycin dimers. Antimicrob Agents Chemother. 2015 Jul; 59(7):3899-905.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.